An open-label observational study of Tirosint (levothyroxine sodium) capsules in hypothyroidism patients who are inadequately controlled with, or intolerant of, traditional levothyroxine (T4) tablets

Trial Profile

An open-label observational study of Tirosint (levothyroxine sodium) capsules in hypothyroidism patients who are inadequately controlled with, or intolerant of, traditional levothyroxine (T4) tablets

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Levothyroxine sodium (Primary)
  • Indications Hypothyroidism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CONTROL
  • Sponsors Akrimax Pharmaceuticals
  • Most Recent Events

    • 20 Sep 2016 According to an Akrimax Pharmaceuticals media release, the results from this study will be presented at the American Thyroid Association Annual Conference.
    • 22 Aug 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top